Skip to main content

Genevieve Giny Fouda Amou Ou

NIH Rank #745
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10201040Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pediatrics
  • Internal Medicine

NIH Funding · FY2025

Linked Award Amount
$7.4M
Full award amounts, FY2025
Award Records
5
Records listing this PI
Award-Linked Rank
#745
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Genevieve Giny Fouda Amou Ou. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Genevieve Giny Fouda Amou Ou as a PI. Multi-PI records show the full award amount for context.

  • 1R01AI184074-01A1R01
    Leveraging novel pediatric SHIVs to identify biomarkers of prophylactic efficacy of bnAb against breast milk HIV transmission
    $4.7M
    award amount
  • 1P01AI189362-01A1P01
    Translating germline-targeting HIV Env SOSIP immunization of infants: targeting bnAbs in early life
    $945K
    award amount
  • 5R01AI161008-05R01
    Early life B cell responses and inflammation following SARS-CoV-2 infection
    $838.5K
    award amount
  • 5TL1TR002386-09TL1
    J. NRSA Training Core
    $694.9K
    award amount
  • 1R21HD118592-01R21
    Defining and modeling HIV-1-specific antibody function in HIV-1-exposed Infants passively Infused with broadly neutralizing antibodies in the IMPAACT P1112 trial.
    $273.4K
    award amount

Award organization

Organizations that administered FY2025 awards listing Genevieve Giny Fouda Amou Ou as a PI.

FY2025 award administered by Weill Cornell Medicine (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Weill Cornell Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    $5M Cumulative Funding
  6. 2025
    Entered Top 50% Nationally
    Ranked #745
  7. 2025
    Entered Top 25% Nationally
    Ranked #745
  8. 2025
    Entered Top 10% Nationally
    Ranked #745
  9. 2025
    Entered Top 5% Nationally
    Ranked #745
  10. 2025
    R01 Grant Holder
  11. 2025
    Program/Center Grant Leader
  12. 2026
    $10M Cumulative Funding